Veterinary Medicines

Narcostop 5 mg/ml, solution for injection for cats and dogs

Authorised
  • Atipamezole hydrochloride
Download as PDF

Product identification

Medicine name:
Narcostop 5 mg/ml, solution for injection for cats and dogs
Narcostop 5 mg/ml injekció kutyák és macskák részére
Active substance:
  • Atipamezole hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Atipamezole hydrochloride
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AB90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Cardboard box with 5 vials containing 10 ml. Clear glass (type I) vial with bromobutylrubber stopper (type I) containing 10 ml solution for injection.
  • Cardboard box with 10 vials containing 10 ml. Clear glass (type I) vial with bromobutylrubber stopper (type I) containing 10 ml solution for injection.
  • Cardboard box with 1 vial containing 10 ml. Clear glass (type I) vial with bromobutylrubber stopper (type I) containing 10 ml solution for injection.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 2739/X/25 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0139/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."